Morphologic transformation of follicular lymphoma is associated with somatic mutation of the translocated bcl-2 gene

Blood

Volumn 88, Issue 10, 1996, Pages 3937-3944

  Matolcsy, András ^b   Casali, Paolo ^b   Warnke, Roger A ^b   Knowles, Daniel M ^a  

^a WEILL CORNELL MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT;

ARTICLE; CHROMOSOME TRANSLOCATION 14; DNA SEQUENCE; FOLLICULAR LYMPHOMA; GENE MUTATION; GENE TRANSLOCATION; GENITAL MALFORMATION; HUMAN; HUMAN CELL; HUMAN TISSUE; LARGE CELL LYMPHOMA; MALIGNANT TRANSFORMATION; NONHODGKIN LYMPHOMA; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; POINT MUTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEQUENCE ANALYSIS; SINGLE STRAND CONFORMATION POLYMORPHISM; SOMATIC MUTATION;

EID: 0029804050     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v88.10.3937.bloodjournal88103937     Document Type: Article

References (43)

1. Ersbøll J, Schultz HB, Perdersen-Bjergaard J, Nissen NJ: Follicular low-grade non-Hodgkin lymphomas: Long-term outcome with or without tumor progression. Eur J Haematol 42:155, 1989
2. Harris NL, Jaffe ES, Stein H, Banks PM, Chan JKC, Cleary ML, Delsol G, Wolf-Peeters CD, Falini B, Gatter KC, Grogan TM, Isaacson PG, Knowles DM, Mason DY, Muller-Hermelink HK, Pileri SA, Pins MA, Ralfkiaer E, Warnke RA: A revised European-American classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group. Blood 84:1361, 1994
3. Cullen MH, Lister TA, Brearley RL, Shand WS, Stansfeld AG: Histologic transformation of non-Hodgkin's lymphoma. A prospective study. Cancer 44:645, 1979
4. Garvin AJ, Simon RM, Osborne CK, Merrill J, Young RC, Berard CW: An autopsy study of histologic progression in non-Hodgkin's lymphomas: 192 cases from the National Cancer Institute. Cancer 52:393, 1983
5. Hubbard SM, Chabner BA, DeVita VJ, Simon R, Berard CW, Jones RB, Garvin AJ, Canellos GP, Osborne CK, Young RC: Histologic progression in non-Hodgkin's lymphoma. Blood 59:258, 1982
6. Oviatt DL, Vousar JB, Collins RD, Flexner JM, Stein RS: Malignant lymphomas of follicular center cell origin in humans. V. Incidence, clinical features, and prognostic implications of transformation of small cleaved cell nodular lymphoma. Cancer 53:1109, 1984
7. Tsujimoto Y, Gorham J, Cossman J, Jaffe ES, Croce CM: The t(14;18) chromosome translocations involved in B-cell neoplasms result from mistakes in VDJ joining. Science 229:1390, 1985
8. Cleary ML, Sklar J: Nucleotide sequence of a t(14; 18) chromosomal breakpoint in follicular lymphoma and demonstration of a breakpoint cluster region near a transcriptionally active locus on chromosome 18. Proc Natl Acad Sci USA 82:7439, 1985
9. Cleary ML, Galili N, Sklar J: Detection of a second t(14;18) breakpoint cluster region in human follicular lymphomas. J Exp Med 164:315, 1986
10. Tsujimoto Y, Croce CM: Analysis of the structure, transcripts, and protein products of bcl-2, the gene involved in human follicular lymphoma. Proc Natl Acad Sci USA 83:5214, 1986
11. Korsmeyer SJ: Bcl-2 initiates a new category of oncogenes: Regulations of cell death. Blood 80:879, 1992
12. Cleary ML, Galili N, Trela M, Levy R, Sklar J: Single cell origin of bigenotypic and biphenotypic B cell proliferations in human follicular lymphomas. J Exp Med 167:582, 1988
13. Richardson ME, Quanguang C, Filippa DA, Offit K, Hampton A, Koduru PRK, Jhanwar SC, Lieberman PH, Clarkson BD, Chaganti RSK: Intermediate- to high-grade histology of lymphomas carrying t(14;18) is associated with additional nonrandom chromosome changes. Blood 70:444, 1987
14. Whang-Peng J, Knutsen T, Jaffe ES, Steinberg SM, Raffeld M, Zhao WP, Duffey P, Condron K, Yano T, Longo DL: Sequential analysis of 43 patients with non-Hodgkin's lymphoma: Clinical correlation with cytogenetic, histologic, immunophenotyping, and molecular studies. Blood 85:203, 1995
15. Yano T, Jaffe ES, Longo DL, Raffeld M: MYC rearrangements in histologically progressed follicular lymphomas. Blood 80:758, 1992
16. Sander CA, Yano T, Clark HM, Harris C, Longo DL, Jaffe ES, Raffeld M: p53 mutation is associated with progression in follicular lymphomas. Blood 82:1994, 1993
17. Lo Coco F, Gaidano G, Louie DC, Offit K, Chaganti RSK, Dalla-Favera R: p53 mutations are associated with histologic transformation of follicular lymphoma. Blood 82:2289, 1993
18. Seto M, Jaeger U, Hockett RD, Graninger W, Bennett S, Goldman P, Korsmeyer SJ: Alternative promoters and exons, somatic mutation and transcriptional deregulation of the bcl-2-Ig fusion gene in lymphoma. EMBO J 7:123, 1988
19. Hua C, Raffeld M, Ko HS, Fast P, Bakhshi A, Cossman J: Mechanism of bcl2 activation in human follicular lymphoma. Oncogene 5:233, 1990
20. Tanaka S, Louie D, Kant J, Reed JC: Application of a PCR-mismatch technique to the bcl-2 gene: Detection of point mutations in bcl-2 genes of malignancies with a t(14;18). Leukemia 6:153, 1992
21. Tanaka S, Louie DC, Kant JA, Reed JC: Frequent incidence of somatic mutations in translocated bcl2 oncogenes of non-Hodgkin's lymphomas. Blood 79:229, 1992
22. Reed JC, Tanaka S: Somatic point mutations in the translocated bcl-2 genes of non-Hodgkin's lymphomas and lymphocytic leukemias: Implications for mechanisms of tumor progression. Leuk Lymphoma 10:157, 1993
23. H and deletion in the ver region of the same BCL2 allele. Oncogene 8:3073, 1993
24. H/BCL2 translocations in follicular lymphoma. Leukemia 5:548, 1991
25. Miller SA, Dykes DD, Polesky HF: A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16:1215, 1988
26. Crescenzi M, Seto M, Herzig GP, Weiss PD, Griffith RC, Korsmeyer SJ: Thermostable DNA polymerase chain amplification of t(14;18) chromosome breakpoints and detection of minimal residual disease. Proc Natl Acad Sci USA 85:4869, 1988
27. Ngan B, Nourse J, Cleary ML: Detection of chromosomal translocation t(14;18) within the minor cluster region of bcl-2 by polymerase chain reaction and direct genomic sequencing of the enzymatically amplified DNA in follicular lymphomas. Blood 73:1759, 1989
28. Tanaka S, Kant J, Reed JC: G to A polymorphism in the second exon of the bcl2 gene. Nucleic Acids Res 19:1964, 1991
29. Traweek ST, Liu J, Johnson RM, Winberg CD, Rappaport H: High-grade transformation of chronic lymphocytic leukemia and low-grade non-Hodgkin's lymphoma. Genotypic confirmation of clonal identity. Am J Clin Pathol 100:519, 1993
30. H rearrangements in benign lymphoid tissues with follicular hyperplasia. Oncogene 6:2271, 1991
31. Bakhshi A, Wright JJ, Graninger W, Seto M, Owens J, Cossman J, Jensen JP. Goldman P, Korsmeyer SJ: Mechanism of the t(14;18) chromosomal translocation: Structural analysis of both derivative 14 and 18 reciprocal partners. Proc Natl Acad Sci USA 84:2396, 1987
32. Tsujimoto Y, Louie E, Bashir MM, Croce CM: The reciprocal partners of both the t(14;18) and the t(11;14) translocations involved in B-cell neoplasms are rearranged by the same mechanism. Oncogene 2:347, 1988
33. Cotter F, Price C, Zucca E, Young BD: Direct sequence analysis of the 14q+ and 18q- chromosome junctions in follicular lymphoma. Blood 76:131, 1990
34. Cleary ML, Meeker TC, Levy S, Lee E, Trela M, Sklar J, Levy R: Clustering of extensive somatic mutations in the variable region of an immunoglobulin heavy chain gene from a human B cell lymphoma. Cell 44:97, 1986
35. Zelenetz AD, Chen TT, Levy R: Histologic transformation of follicular lymphoma to diffuse lymphoma represents tumor progression by a single malignant B cell. J Exp Med 173:197, 1991
36. Mikraki V, Ladanyi M, Chaganti RS: Structural alterations in the 5′ region of the bcl2 gene in follicular lymphomas with bcl2-mbr or bcl2-mcr rearrangements. Genes Chromosomes Cancer 3:117, 1991
37. McDonell TJ, Deane N, Platt FM, Nunez G, Jaeger U, McKearn JP, Korsmeyer SJ: Bcl-2-immunoglobulin transgenic mice demonstrate extended B cell survival and follicular lymphoproliferation. Cell 57:79, 1989
38. Oltvai ZN, Milliman CL, Korsmeyer SJ: Bcl-2 heterodimerizes in vivo with a conserved homolog, bax, that accelerates programed cell death. Cell 74:609, 1993
39. Boise LH, González-García M, Postema CE, Ding L, Lindsten T, Turka LA, Mao X, Nunez G, Thompson CB: Bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell 74:597, 1993
40. Sato T, Hanada M, Bodrug S, Irie S, Iwama N, Boise LH, Thompson CB, Golemis E, Fong L, Wang H, Reed JC: Interactions among members of the bcl-2 protein family analyzed with a yeast two-hybrid system. Proc Natl Acad Sci USA 91:9238, 1994
41. Yin X, Oltvai ZN, Korsmeyer SJ: HB1 and HB2 domains of bcl-2 are required for inhibition of apoptosis and heterodimerization with bax. Nature 369:321, 1994
42. Fernandez-Sarabia MJ, Bischoff JR: Bcl-2 associates with the ras-related protein R-ras p23. Nature 366:274, 1993
43. Miyashita T, Krajewski S, Krajewska M, Wang HG, Lin HK, Liebermann DA, Hoffman B, Reed JC: Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene 9:1799, 1994